A proposed collaboration with CBmed Ltd., Austria
Curious about the clinical potential
of your probiotic strain?
Identify the most relevant clinical application for your strain through our fully
integrated service offering
From strain characterization and candidate selection to clinical safety, efficacy, and
validation studies, our end-to-end support covers the full development pathway
What We Deliver
Strain Isolation
End-to-end strain isolation and characterization to identify the most promising probiotic candidates.
Strain Characterization
Targeted functional testing to demonstrate pathogen inhibition and immune-modulating potential.
Clinical Expertise
10+ years of expertise in probiotic research, from clinical guidance and method selection to protocol development.
Clinical Pilot Study
Pilot study solutions that generate early human data and support confident development decisions.
Clinical Gold Standard
Clinical validation programs using gold standard study setups, designed to deliver robust evidence for market-ready positioning.
Special Offer
We offer a no-cost initial test phase as a low-risk entry point for your team to assess our platform performance, scientific quality, and collaborative execution in a real project setting.
This entry phase is designed to generate early prioritization insights while establishing the basis for broader strategic collaboration.
In this introductory phase, we will:
- Screen the indirect pathogen inhibition activity of one selected probiotic strain against 2 clinically relevant pathogens from our collection.
- Demonstrate the quality, relevance, and reproducibility of our screening approach
- Build confidence in our team, project delivery, and reporting standard
Proposed Timeline
NO COST Initital test phase (1-4 Weeks)
One selected probiotic strain against 2 clinically relevant pathogens
Strain Characterization (6-12 Months)
Understand the functional potential of your probiotic strain and define the clinical application
Clinical Exploration (1-3 Years)
Stepwise approach to de-risk development, safety, efficacy, validation studies